|
|
Joanna Groom, Susan L. Kalled, Anne H. Cutler, Carl Olson, Stephen A. Woodcock, Pascal Schneider, Jurg Tschopp, Teresa G. Cachero, Marcel Batten, Julie Wheway, Davide Mauri, Dana Cavill, Tom P. Gordon, Charles R. Mackay, Fabienne Mackay
J Clin Invest. 2002;
109(1):59
doi:10.1172/JCI14121
Abstract |
Full text
| PDF

B
AFF (BLyS, TALL-1, THANK, zTNF4) is a member of the TNF superfamily that specifically regulates B lymphocyte proliferation and survival. Mice transgenic (Tg) for BAFF develop an autoimmune condition similar to systemic lupus erythematosus. We now demonstrate that BAFF Tg mice, as they age, develop a secondary pathology reminiscent of Sjögren’s syndrome (SS), which is manifested by severe sialadenitis, decreased saliva production, and destruction of submaxillary glands. In humans, SS also correlates with elevated levels of circulating BAFF, as well as a dramatic upregulation of BAFF expression in inflamed salivary glands. A likely explanation for disease in BAFF Tg mice is excessive survival signals to autoreactive B cells, possibly as they pass through a critical tolerance checkpoint while maturing in the spleen. The marginal zone (MZ) B cell compartment, one of the enlarged B cell subsets in the spleen of BAFF Tg mice, is a potential reservoir of autoreactive B cells. Interestingly, B cells with an MZ-like phenotype infiltrate the salivary glands of BAFF Tg mice, suggesting that cells of this compartment potentially participate in tissue damage in SS and possibly other autoimmune diseases. We conclude that altered B cell differentiation and tolerance induced by excess BAFF may be central to SS pathogenesis.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(107)
| Title and authors |
Publication |
Year |
Cytotoxics or biologicals in the treatment of Sjögren’s syndrome?
Clio P Mavragani, Michael Voulgarelis, Haralampos M Moutsopoulos
|
International Journal of Clinical Rheumatology
|
2012 |
B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha
Yusuke Kajiyama, Kentaro Kikuchi, Atsuko Takai, Naomi Hosoya, Hiromi Hoshino, Kunihiko Hino, Hiroshi Miyakawa
|
Clinical and Developmental Immunology
|
2012 |
Impaired expression of Act1mRNA in B cells of patients with Sjögren's syndrome
Yasuko NAKAGAWA, Hiroshi KATAOKA, Takashi KURITA, Hisako NAKAGAWA, Shinsuke YASUDA, Tetsuya HORITA, Tatsuya ATSUMI, Takao KOIKE
|
Jpn. J. Clin. Immunol.
|
2012 |
B cell depletion in autoimmune diabetes: insights from murine models
Jayne L Chamberlain, Kesley Attridge, Chun Jing Wang, Gemma A Ryan, Lucy SK Walker
|
Expert Opin. Ther. Targets
|
2011 |
Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
Petra M Meiners, Arjan Vissink, Cees GM Kallenberg, Frans GM Kroese, Hendrika Bootsma
|
Expert Opin. Biol. Ther.
|
2011 |
Liver-expressed Ig superantigen induces tolerance of polyclonal B cells by clonal deletion not to receptor editing
T. Ota, M. Ota, B. H. Duong, A. L. Gavin, D. Nemazee
|
Journal of Experimental Medicine
|
2011 |
Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD
W. B. Clark, K. D. Brown-Gentry, D. C. Crawford, K.-H. Fan, J. Snavely, H. Chen, B. N. Savani, A. Kassim, J. P. Greer, F. G. Schuening, B. G. Engelhardt, M. H. Jagasia
|
Blood
|
2011 |
The Plasma Concentration of the B Cell Activating Factor Is Increased in Children With Acute Malaria
E. Nduati, A. Gwela, H. Karanja, C. Mugyenyi, J. Langhorne, K. Marsh, B. C. Urban
|
Journal of Infectious Diseases
|
2011 |
Current concepts: mouse models of Sjögren's syndrome.
Tegan N Lavoie, Byung Ha Lee, Cuong Q Nguyen
|
J. Biomed. Biotechnol.
|
2011 |
Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study
G. O. Eilertsen, M. Van Ghelue, H. Strand, J. C. Nossent
|
Rheumatology
|
2011 |
|